Drugs /

immune checkpoint inhibitor

Back to Drugs List

Overview

NCI Definition [1]:
An agent that inhibits any of the immune checkpoint inhibitory proteins.

Clinical Trials

View Clinical Trials for immune checkpoint inhibitor

Immune checkpoint inhibitor has been investigated in 4 clinical trials, of which 3 are open and 1 is closed. Of the trials investigating immune checkpoint inhibitor, 2 are phase 1/phase 2 (1 open) and 2 are no phase specified (2 open).

Malignant solid tumor is the most common disease being investigated in immune checkpoint inhibitor clinical trials [2].

Drug Details

Synonyms [2]:
immune checkpoint inhibitor
NCIT ID [1]:
C143250

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.